Related Experiment Video
Updated: May 3, 2026

Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice
Published on: September 17, 2015
Isoproterenol induces activity fronts in fed dogs through somatostatin release
Abstract:
We confirmed previous studies by others that intravenous somatostatin infusions (1.4 and 2.5 micrograms/kg X h) induced jejunal activity fronts in fed dogs. This finding, coupled with earlier demonstrations that somatostatin is released from the stomach and pancreas in vitro by isoproterenol, led us to investigate the possible role of somatostatin in mediating isoproterenol-induced activity fronts. Plasma somatostatin and motilin concentrations were determined after a meat-base meal, before and after isoproterenol infusions (0.5 micrograms/kg X min). Jejunal activity fronts were initiated in 15 of 17 experiments an average of 25 min after the start of the isoproterenol infusion. The concentration of motilin did not change, but somatostatin concentrations increased progressively beginning 15 min after starting the isoproterenol infusion. Thus, isoproterenol released somatostatin in vivo and this release was associated with jejunal activity fronts. The rise in plasma somatostatin concentration was similar to that obtained after somatostatin infusions, although in the latter experiments the activity fronts began soon after initiation of the somatostatin infusion. The results suggest that isoproterenol-induced activity fronts are mediated by somatostatin. We speculate that beta-adrenergic nerves may induce activity fronts through somatostatin release, possibly in situations such as extreme stress.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Heart Failure Drugs: Inotropic Agents

